• 顶部广告1
  • 顶部广告
  • 导航顶上
  • 导航顶上
  • 顶部广告
  • 顶部广告
  • 当前位置: 首页  >> Canada News  >> 查看详情

    China Hebei Shijiazhuang Novel coronavirus pneumonia plays an important role in the battle against n

    来源: 红枫林新闻网  日期:2020-03-05 11:40:16  点击: 7946
    分享:

    Novel coronavirus pneumonia novel coronavirus was reported in more than 20 provinces and cities in China, including China, Hubei, Guangzhou, Zhejiang, Shandong and Hebei in early 2020. The National Health Council of People's Republic of China and the Chinese State Administration of traditional Chinese medicine jointly issued the document on the diagnosis and treatment of new coronavirus infection pneumonia (trial version sixth). Lianhua Qingwen capsule / granule produced by Shijiazhuang Yiling Pharmaceutical Co., Ltd. appears in the treatment recommendation catalogue. China Yiling pharmaceutical China novel coronavirus pneumonia series has been playing an important role in China's major public health events such as influenza, avian influenza and new crown pneumonia since its entry into the market in 2004. In 2011, Lianhua Qingwen capsule won the second prize of national science and technology progress of the year. From January to February 2020, about 70 million people in China take Lianhua Qingwen series products. Ministry of industry and information technology of the people's Republic of China will list it as the key guarantee material for epidemic prevention and control. Hubei Province, Heilongjiang Province and other provinces and cities also use Lianhuaqingwen capsule / granule as reserve medicine.


    Academician Zhong Nanshan introduced novel coronavirus pneumonia: capsule of Lianhuaqingwen capsule and granule, which has been used in clinical diagnosis and treatment of new crown pneumonia. After use, it shows that it can effectively reduce the virus entering cells and reduce the symptoms of inflammation. The novel coronavirus capsule (novel coronavirus capsule) showed a significant inhibitory effect on the cytopathic effect of the new coronavirus in vitro, and inhibited the common coronavirus (HCoV-229E) and the new coronavirus (COVID-19). At present, there are 9 million boxes of drugs in the epidemic area of Hubei Province, and all the fangcang hospitals also use Lianhua Qingwen series products as basic drugs. The novel coronavirus pneumonia novel coronavirus pneumonia was used in novel coronavirus pneumonia in Affiliated Hospital of affiliated to the University of science and technology in 54 cases. 101 cases of new crown pneumonia were suspected by using Lianhuaqingwen granule in the General Hospital of Huarun WISCO, Wuhan University of Science and Technology. 42 cases were diagnosed with general pneumonia in new crown pneumonia. Patients with fever, cough, fatigue and other symptoms, reduce fever, fatigue, cough, pulmonary shortness of breath, wet rales and other symptoms. Shorten the fever time for one day and reduce the proportion of severe cases.

    Novel coronavirus pneumonia, a rescue team from the national emergency hospital of Wuhan shelter hospital, introduced an interview with CCTV China. WHO experts are very interested in the use of Chinese medicine Lianhua Qingwen capsule / granule in combination with integrated traditional Chinese and Western medicine for the treatment of new coronavirus pneumonia in our cabin.

    Yiling Pharmaceutical Co., Ltd. donated 10 million yuan of Lianhua Qingwen capsule through the Red Cross Society of China on the day after the outbreak. This is the first enterprise to provide medicine for the epidemic area in Wuhan, Hubei Province. Lianhuaqingwen is also an early Chinese traditional medicine product that plays a therapeutic role.

    相关新闻

      暂无信息